Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6407 ARTÍCULOS , VIENDO DEL 5386 AL 5400

The role of DAT-SPECT in movement disorders

Kägi G, Bhatia KP, Tolosa E.

J Neurol Neurosurg Psychiatry. 2010 Jan;81(1):5-12. doi: 10.1136/jnnp.2008.157370.

Study of the prevalence of Parkinson's disease using dopamine transporter imaging

Kim JM, Kim JS, Kim KW, Lee SB, Park JH, Lee JJ, Kim YK, Kim SE, Jeon BS.

Neurol Res. 2010 Oct;32(8):845-51. doi: 10.1179/016164109X12581096796396. Epub 2009 Dec 21.

INPH and Parkinson disease: differentiation by levodopa response

Morishita T, Foote KD, Okun MS.

Nat Rev Neurol. 2010 Jan;6(1):52-6. doi: 10.1038/nrneurol.2009.195.

Complications and side effects of deep brain stimulation in the posterior subthalamic area

Fytagoridis A, Blomstedt P.

Stereotact Funct Neurosurg. 2010;88(2):88-93. doi: 10.1159/000271824. Epub 2010 Jan 5.

Differentiating vascular parkinsonism from idiopathic Parkinson's disease: a systematic review

Kalra S, Grosset DG, Benamer HT.

Mov Disord. 2010 Jan 30;25(2):149-56. doi: 10.1002/mds.22937.

The reliability of transcranial duplex scanning in parkinsonian patients: comparison of different observers and ultrasound systems

Vlaar A, Tromp SC, Weber WE, Hustinx RM, Mess WH.

Ultraschall Med. 2011 Jan;32 Suppl 1:S83-8. doi: 10.1055/s-0028-1109945. Epub 2010 Jan 21.

Treatment strategies for Parkinson's disease

Yuan H, Zhang ZW, Liang LW, Shen Q, Wang XD, Ren SM, Ma HJ, Jiao SJ, Liu P.

Neurosci Bull. 2010 Feb;26(1):66-76. doi: 10.1007/s12264-010-0302-z.

Analysis of LINGO1 (rs9652490) polymorphism in sporadic Parkinson's disease in a Polish population, and a meta-analysis

Białecka M, Kurzawski M, Tan EK, Drozdzik M.

Neurosci Lett. 2010 Mar 12;472(1):53-5. doi: 10.1016/j.neulet.2010.01.055. Epub 2010 Feb 1.

Low-frequency repetitive transcranial magnetic stimulation and off-phase motor symptoms in Parkinson's disease

Filipović SR, Rothwell JC, Bhatia K.

J Neurol Sci. 2010 Apr 15;291(1-2):1-4. doi: 10.1016/j.jns.2010.01.017. Epub 2010 Feb 12.

Gene therapy in Parkinson's disease: rationale and current status

Feng LR, Maguire-Zeiss KA.

CNS Drugs. 2010 Mar;24(3):177-92. doi: 10.2165/11533740-000000000-00000.

How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor

Louis ED, Ferreira JJ.

Mov Disord. 2010 Apr 15;25(5):534-41. doi: 10.1002/mds.22838.

Effective long-term subthalamic stimulation in PARK8 positive Parkinson's disease

Breit S, Wächter T, Schmid-Bielenberg D, Weiss D, Leitner P, Nägele T, Freudenstein D, Gasser T, Krüger R.

J Neurol. 2010 Jul;257(7):1205-7. doi: 10.1007/s00415-010-5493-8. Epub 2010 Feb 23.

Effects of caffeine in Parkinson's disease: from neuroprotection to the management of motor and non-motor symptoms

Prediger RD.

J Alzheimers Dis. 2010;20 Suppl 1:S205-20. doi: 10.3233/JAD-2010-091459.

Alzheimer's disease, Parkinson's disease and essential tremor: three common degenerative diseases with shared mechanisms?

Louis ED, Benito-León J.

Eur J Neurol. 2010 Jun 1;17(6):765-6. doi: 10.1111/j.1468-1331.2010.02976.x. Epub 2010 Feb 26.

Parkinson's disease: oxidative stress and therapeutic approaches

Surendran S, Rajasankar S.

Neurol Sci. 2010 Oct;31(5):531-40. doi: 10.1007/s10072-010-0245-1. Epub 2010 Mar 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias